Skip to main navigation Skip to search Skip to main content

Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals from the Neurocritical Care Society and the Society of Critical Care Medicine

  • Jennifer A. Frontera
  • , John J. Lewin
  • , Alejandro A. Rabinstein
  • , Imo P. Aisiku
  • , Anne W. Alexandrov
  • , Aaron M. Cook
  • , Gregory J. Del Zoppo
  • , Monisha Kumar
  • , Ellinor I.B. Peerschke
  • , Michael F. Stiefel
  • , Jeanne S. Teitelbaum
  • , Katja E. Wartenberg
  • , Cindy L. Zerfoss
  • Case Western Reserve University
  • Johns Hopkins University
  • Mayo Clinic Rochester, MN
  • University of Tennessee Health Science Center
  • Australian Catholic University
  • University of Kentucky
  • University of Washington
  • University of Pennsylvania
  • Memorial Sloan-Kettering Cancer Center
  • New York Medical College
  • Hospital du Sacre Coeur de Montreal
  • McGill University
  • Martin Luther University Halle-Wittenberg
  • Centra Lynchburg General Hospital

Research output: Contribution to journalArticlepeer-review

114 Scopus citations
Original languageEnglish
Pages (from-to)2251-2257
Number of pages7
JournalCritical Care Medicine
Volume44
Issue number12
DOIs
StatePublished - Dec 1 2016

Keywords

  • anticoagulant
  • coagulopathy
  • guideline
  • intracranial hemorrhage
  • reversal

Fingerprint

Dive into the research topics of 'Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals from the Neurocritical Care Society and the Society of Critical Care Medicine'. Together they form a unique fingerprint.

Cite this